(Press-News.org)
“AL amyloidosis is a fatal disease and systemic therapy is required to prevent deposition of amyloid in other organs and prevent progressive organ failure.”
BUFFALO, NY- May 5, 2023 – A new review paper was published in Oncotarget's Volume 14 on April 26, 2023, entitled, “Systemic AL amyloidosis: current approach and future direction.”
In this review, researchers Maroun Bou Zerdan, Lewis Nasr, Farhan Khalid, Sabine Allam, Youssef Bouferraa, Saba Batool, Muhammad Tayyeb, Shubham Adroja, Mahinbanu Mammadii, Faiz Anwer, Shahzad Raza, and Chakra P. Chaulagain from SUNY Upstate Medical University, University of Texas MD Anderson Cancer Center, Monmouth Medical Center, University of Balamand, Cleveland Clinic Ohio, UnityPoint Methodist, Houston Methodist Cancer Center, and Cleveland Clinic Florida report the literature on the latest treatment updates of Systemic Light chain (AL) amyloidosis and the ongoing clinical trials highlighting the future treatments.
“In this manuscript, we discuss the general approach towards treating patients with amyloidosis and dive into the future perspectives in this multi-systemic disease.”
Systemic AL amyloidosis is a monoclonal plasma cell proliferative disorder characterized by deposition of amyloidogenic monoclonal light chain fragments causing organ dysfunction. It is a fatal disease and if not diagnosed and treated early can lead to organ failure and potentially death. The renal system along with the cardiovascular system are the most common organs involved, but other organs such as the gut and liver can be involved as well.
The initial evaluation of patients requires confirming the diagnosis with tissue biopsy and staining with Congo red followed by confirmatory typing with mass spectrometry of the Congo red positive tissue. Then establishing the extent of the organs involvement by various staging and biomarkers testing. The treatment options and the tolerability of therapy depend on the disease staging, frailty and co-morbidities.
The autologous hematopoietic cell transplantation (HCT) after high dose melphalan therapy is an effective strategy which is usually done after initial bortezomib induction therapy. Unfortunately, most systemic AL amyloidosis patients are not candidates for HCT due to frailty, old age, multi-organ involvement, and renal or heart failure at the time of diagnosis. While it is widely accepted that the patients need to be treated until they achieve complete hematologic response, the maintenance therapy after HCT is not well established in AL amyloidosis.
“The relationship between AL amyloidosis and MGUS is less clear, but some studies suggest that the risk of developing AL amyloidosis may be increased in patients with MGUS. It is important for patients with these conditions to undergo regular monitoring and evaluation for signs of AL amyloidosis, as early diagnosis and treatment can improve outcomes.”
Read the full review: DOI: https://doi.org/10.18632/oncotarget.28415
Correspondence to: Chakra P. Chaulagain
Email: chaulac@ccf.org
Keywords: amyloidosis, management
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
Artificial intelligence (AI) tools can drive cars, monitor and adjust the temperature in your home, and chat with you online. AI could help public health officials, community workers, and clinics efficiently direct and allocate resources and better target interventions to improve health outcomes during disasters and public health emergencies.
“The COVID-19 pandemic highlighted a need for new approaches to resource allocation during public health crises—approaches that simultaneously serve our society’s most vulnerable communities, improve our overall health and well-being, and maximize impact,” ...
Des Plaines, IL — There are unlimited opportunities for career growth in the U.S. Department of Veterans Affairs (VA) health system and this option should be recognized by medical students considering emergency medicine as a potential career, and by emergency medicine residents as well. This is the message of a perspective piece titled, The hidden jewel of emergency medicine careers: Why it's time to explore the VA. The piece introduces the April 2023 special issue of Academic ...
The Alliance Board of Directors has elected Evanthia Galanis, MD, as Group Chair-Elect of the Alliance for Clinical Trials in Oncology at the 2023 Alliance Spring Virtual Group Meeting on May 5. Dr. Galanis will take office in November 2023 and will serve a six-year term.“I’m honored to be elected to serve as Group Chair of the Alliance,” Dr. Galanis said. “I am excited to lead an organization whose mission is to reduce the impact of cancer by uniting a broad community of scientists and clinicians who are committed to the prevention and treatment ...
DENVER — (MAY 5, 2023) For the past two decades, there has been a major resurgence in progressive massive fibrosis (PMF), (also known as black lung) among coal miners, leading researchers from National Jewish Health and across the country to examine what job duties might be putting them at risk. Current federal regulations require routine monitoring of dust levels in specific “high risk” jobs in underground coal mines, mainly jobs near the coal seam where coal is mined from surrounding rock. During the study, crystalline silica, a component of coal mine dust, was found in the lungs of coal miners whose jobs had not been targeted for exposure monitoring based on current ...
Football players who have had repetitive head trauma and concussion are at heightened risk for chronic traumatic encephalopathy (CTE), an irreversible condition that leads to dementia. But not every case of cognitive decline means CTE, as illustrated by a new case study published by researchers from Mass General Brigham in Current Sports Medicine Reports.
In the publication, Adam Tenforde, MD, a physician in Mass General Brigham’s Sports medicine program and medical director of the Spaulding National Running Center, co-authored a study that described the case ...
By Suhtling Wong | May 1, 2023 11:19 am
Bacteria naturally adapt to various environmental stimuli and as they mutate, these changes can make them resistant to drugs that would kill or slow their growth.
In a recent article published in PLoS Genetics, UCF College of Medicine microbiologist Dr. Salvador Almagro-Moreno uncovers the evolutionary origins of antimicrobial resistance (AMR) in bacteria. His studies on the bacterium that causes ...
Led by Jizhong Zhou, Ph.D., the director of the Institute for Environmental Genomics at the University of Oklahoma, an international research team conducted a long term experiment that found that climate warming reduced the diversity of and significantly altered the community structure of soil archaea. Their findings are published in the journal Nature Climate Change.
At the microbiological level, life can be described as belonging to one of three kingdoms – how species are described in relation to one another. Eukarya contains complex organisms like animals and ...
PHILADELPHIA (May 5, 2023) - Despite breastfeeding being recommended for at least two years, only 36 percent of all infants are still breastfed at their first birthday. Black/African American mothers are least likely to initiate breastfeeding with initiation rates of only 74 percent compared to 90 percent of Asian mothers with a national average of 84 percent. Given the disparities in breastfeeding initiation, there are likely to be equivalent disparities in breastfeeding duration.
New research from the University of Pennsylvania School of Nursing (Penn Nursing) published in the journal Breastfeeding ...
NEWPORT NEWS, VA – Experts in high-performance computing and data management are gathering in Norfolk next week for the 26th International Conference on Computing in High Energy and Nuclear Physics (CHEP2023). Held approximately every 18 months, this high-impact conference will be held at the Norfolk Marriott Waterside in Norfolk, Va., May 8-12. CHEP2023 is hosted by the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility in nearby Newport News, Va. This is the first in-person CHEP conference to be held since 2019.
Science is driven by data. As research has progressed, so has the sheer volume of scientific data. The CHEP2023 conference ...
”When pentacene is excited by light, the electrons in the material rapidly react,” explains Prof. Ralph Ernstorfer, a senior author of the study. “It was an open and very disputed question whether a photon excites two electrons directly or initially one electron, which subsequently shares its energy with another electron.”
To unravel this mystery the researchers used time- and angle-resolved photoemission spectroscopy, a cutting-edge technique to observe the dynamics of electrons on the femtosecond time scale, which is a billionth of a ...
